Stephanie Korn
Researcher Next ID · RN-025512
Researcher · Medicine
University of Applied Sciences Mainz
Mainz, Romania
- Works count
- 295
- Citation count
- 11,703
- H-index
- 44
- i10-index
- 87
Research interests
Publications
Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease
New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1708208
Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial
The Lancet · 2016 · https://doi.org/10.1016/s0140-6736(16)31322-8
Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials
The Lancet Respiratory Medicine · 2015 · https://doi.org/10.1016/s2213-2600(15)00042-9
Efficacy and safety of aclidinium bromide/formoterol fumarate fixed-dose combinations compared with individual components and placebo in patients with COPD (ACLIFORM-COPD): a multicentre, randomised study
BMC Pulmonary Medicine · 2014 · https://doi.org/10.1186/1471-2466-14-178
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
The Lancet · 2012 · https://doi.org/10.1016/s0140-6736(12)60988-x
Current projects
No projects listed.